盐酸纳洛酮联合丹参注射液治疗新生儿缺氧缺血性脑病的临床观察
x
请在关注微信后,向客服人员索取文件
篇名: | 盐酸纳洛酮联合丹参注射液治疗新生儿缺氧缺血性脑病的临床观察 |
TITLE: | |
摘要: | 目的:观察盐酸纳洛酮联合丹参注射液治疗新生儿缺氧缺血性脑病(HIE)的临床疗效及安全性。方法:104例HIE患儿按照随机数字表法分为观察组和对照组,各52例。对照组患儿给予盐酸纳洛酮注射液0.02 mg/kg,ivgtt,qd,以及常规对症治疗;观察组患儿在对照组基础上给予丹参注射液4~6 ml加入10%葡萄糖注射液20 ml中,ivgtt,qd。两组患儿疗程均为7 d。比较两组患儿临床疗效、症状和体征恢复情况,血清基质金属蛋白酶(MMP)9、白细胞介素(IL)6、肿瘤坏死因子(TNF)α水平,脑血流动力学参数以及不良反应发生情况。结果:两组患儿治疗前的血清MMP-9、IL-6、TNF-α及脑血流动力学参数比较,差异均无统计学意义(P>0.05)。观察组患儿总有效率(92.31%)明显高于对照组(75.00%),治疗后意识障碍恢复时间、原始反射恢复时间和肌张力恢复时间均明显短于对照组,血清MMP-9、IL-6和TNF-α水平均明显低于对照组,收缩期峰值流速(PSFV)、舒张末期流速(EDFV)明显高于对照组,差异均有统计学意义(P<0.05);观察组患儿治疗后阻力指数(RI)低于对照组,但差异无统计学意义(P>0.05)。两组患儿均未见明显不良反应发生。结论:盐酸纳洛酮联合丹参注射液可明显改善新生儿HIE症状、体征恢复情况,降低血清MMP-9、IL-6、TNF-α水平,改善脑血流动力学参数水平,且安全性较好。 |
ABSTRACT: | OBJECTIVE: To observe clinical efficacy and safety of naloxone hydrochloride combined with Danshen injection in the treatment of neonatal hypoxic ischemic encephalopathy (HIE). METHODS: 104 patients with HIE were randomly divided into observation group and control group with 52 cases in each group. The control group was treated with Naloxone hydrochloride injection 0.02 mg/kg,ivgtt,qd and conventional symptomatic treatment; while observation group was additionally treated with Danshen injection 4-6 ml+10% Glucose injection 20 ml, ivgtt, qd, on the basis of the control group. Treatment course of 2 groups lasted for 7 d. Clinical efficacy, symptom and sign recovery of 2 groups were compared, as well as levels of serum MMP-9, IL-6 and TNF-α, cerebral hemodynamic parameters and ADR. RESULTS: There was no statistical significance in MMP-9,IL-6,TNF-α and cerebral hemodynamic parameters before treatment (P>0.05). The total effective rate of observation group (92.31%) was significantly higher than that of control group (75.00%); after treatment, the recovery time of consciousness disturbance, primitive reflex and muscle tension in the observation group were shorter than those in the control group; the levels of serum MMP-9, IL-6 and TNF-α in observation group were significantly lower than those in control group; peak systolic flow velocity (PSFV), end-diastolic flow velocity (EDTV) were higher in the observation group than in the control group, with statistical significance (P<0.05); resistance index (RI) was lower than in control group, but without statistical significance (P>0.05). No ADR was observed in 2 groups. CONCLUSIONS: Naloxone hydrochloride combined with Danshen injection can significantly promote HIE and signs recovery, reduce the levels of serum MMP-9, IL-6 and TNF-α, and improve hemodynamic parameters with good safety. |
期刊: | 2016年第27卷第23期 |
作者: | 娄元俊,史华,单海军,曹彩虹 |
AUTHORS: | LOU Yuanjun,SHI Hua,SHAN Haijun,CAO Caihong |
关键字: | 丹参注射液;盐酸纳洛酮注射液;新生儿缺氧缺血性脑病;疗效;基质金属蛋白酶9;白细胞介素6;肿瘤坏死因子α;脑血流动力学参数 |
KEYWORDS: | Danshen injection; Naloxone hydrochloride injection; Neonatal hypoxic ischemic encephalopathy; Therapeutic efficacy; MMP-9, IL-6; TNF-α; Cerebral hemodynamic parameters |
阅读数: | 249 次 |
本月下载数: | 1 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!